Equity Method Investments - Schedule of Summarized Financial Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||
---|---|---|---|---|---|---|---|
Jun. 30, 2020 |
Mar. 31, 2020 |
Jun. 30, 2019 |
Mar. 31, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Dec. 31, 2019 |
|
Statement of Financial Position [Abstract] | |||||||
Current assets | $ 146,877 | $ 146,877 | $ 158,968 | ||||
Current liabilities | 1,018,117 | 1,018,117 | 222,325 | ||||
Income Statement [Abstract] | |||||||
Net income (loss) | (58,033) | $ (80,925) | $ (38,460) | $ (37,609) | (138,958) | $ (76,069) | |
Carrying value in our equity method investments | 62,284 | 62,284 | 78,886 | ||||
Equity Method Investment, Nonconsolidated Investee or Group of Investees | |||||||
Statement of Financial Position [Abstract] | |||||||
Current assets | 30,676 | 30,676 | 50,588 | ||||
Non-current assets | 26,131 | 26,131 | 25,370 | ||||
Current liabilities | 6,779 | 6,779 | 26,593 | ||||
Non-current liabilities | 9,670 | 9,670 | 2,207 | ||||
Income Statement [Abstract] | |||||||
Revenue | 4,271 | 37,548 | 35,148 | 69,589 | |||
Net income (loss) | (1,326) | $ 8,077 | 5,762 | $ 14,842 | |||
Carrying value in our equity method investments | $ 62,284 | $ 62,284 | $ 78,886 |
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of obligation due after one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|